Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases

被引:171
作者
Bagan, JV
Murillo, J
Jimenez, Y
Poveda, R
Milian, MA
Sanchis, JM
Silvestre, FJ
Scully, C
机构
[1] Univ Valencia, Univ Gen Hosp, Dept Stomatol, Serv Estomatol, Valencia 46014, Spain
[2] Univ Peset Hosp, Dept Stomatol, Valencia, Spain
[3] UCL, Eastman Dent Inst Oral Hlth Care Sci, London, England
[4] UCL, Int Ctr Excellence Dent, London, England
关键词
bisphosphonates; cancer; chemotherapy; jaws; osteonecrosis;
D O I
10.1111/j.1600-0714.2004.00269.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: We present a series of 10 patients with osteonecrosis of the jaws (ONJ) that appeared following cancer chemotherapy. MATERIAL AND METHODS: Of the 10 cases with ONJ, six had bone metastases from breast cancers and the other four had multiple myeloma. We analysed the location of bone metastases, as well as the characteristics of the ONJ, and the drugs with which they had been treated for their bone metastases. RESULTS: Of the 10 patients, all had ONJ in the mandible; 50% also had maxillary involvement. The average number of areas of painful exposed was 2.1 per patient (range 1-5). In seven patients a tooth extraction preceded the onset of ONJ. Two patients developed oroantral communications and another a cutaneous fistula to the neck with suppuration. In all the 10 patients the histopatholological diagnosis was of chronic osteomyelitis without evidence of metastatic disease to the jaws. All the patients had received treatment for their malignant bone disease with bisphosphonates. These were the only drugs that all patients had received. CONCLUSION: ONJ appears to have a relationship with the use of bisphosphonates.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 17 条
[1]   Alendronate in the treatment of avascular necrosis of the hip [J].
Agarwala, S ;
Sule, A ;
Pai, BU ;
Joshi, VR .
RHEUMATOLOGY, 2002, 41 (03) :346-347
[2]   New foundations in understanding osteonecrosis of the jaws [J].
Assael, LA .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (02) :125-126
[3]   Systemic alendronate prevents resorption of necrotic bone during revascularization.: A bone chamber study in rats -: art. no. 19 [J].
Åstrand, J ;
Aspenberg, P .
BMC MUSCULOSKELETAL DISORDERS, 2002, 3 (1) :1-5
[4]   Severe oral ulcerations induced by alendronate [J].
Demerjian, N ;
Bolla, G ;
Spreux, A .
CLINICAL RHEUMATOLOGY, 1999, 18 (04) :349-350
[5]  
Fournier P, 2002, CANCER RES, V62, P6538
[6]   Alendronate-related oral mucosa ulcerations [J].
Gonzalez-Moles, MA ;
Bagan-Sebastian, JV .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (10) :514-518
[8]   Bisphosphanates and oral cavity avascular bone necrosis [J].
Migliorati, CA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4253-4254
[9]   Bisphosphonates and bone necrosis [J].
Pogrel, MA .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (03) :391-392
[10]   A case of maxillary necrosis [J].
Pogrel, MA ;
Miller, CE .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 61 (04) :489-493